Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03317158
Title ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the Bladder
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Noah Hahn, M.D.
Indications

non-invasive bladder urothelial carcinoma

Therapies

Durvalumab

BCG solution + Durvalumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.